{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:19:56Z","timestamp":1787847596055,"version":"build-2784847793"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.4103\/jpn.jpn_76_20","type":"journal-article","created":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T13:04:06Z","timestamp":1626008646000},"page":"273-276","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Treatable Neurodegenerative Disorder"],"prefix":"10.4103","volume":"16","author":[{"given":"Vykuntaraju K","family":"Gowda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balamurugan","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varunvenkat M","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K","family":"Shivappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20240831","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1469-8749.2004.tb00451.x","article-title":"Cerebral folate deficiency","volume":"46","author":"Ramaekers","year":"2004","journal-title":"Dev Med Child Neurol"},{"key":"R3-3-20240831","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev.nutr.21.1.255","article-title":"New perspectives on folate catabolism","volume":"21","author":"Suh","year":"2001","journal-title":"Annu Rev Nutr"},{"key":"R4-3-20240831","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.addr.2004.01.002","article-title":"A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro","volume":"56","author":"Kamen","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"R5-3-20240831","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.addr.2004.01.010","article-title":"Folate receptor endocytosis and trafficking","volume":"56","author":"Sabharanjak","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"R6-3-20240831","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0005-2736(01)00340-6","article-title":"Localization of the murine reduced folate carrier as assessed by immuno-histochemical analysis","volume":"1513","author":"Wang","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"R7-3-20240831","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1515\/cclm-2012-0543","article-title":"Clinical recognition and aspects of the cerebral folate deficiency syndromes","volume":"51","author":"Ramaekers","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"R8-3-20240831","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ajhg.2009.08.005","article-title":"Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism","volume":"85","author":"Steinfeld","year":"2009","journal-title":"Am J Hum Genet"},{"key":"R9-3-20240831","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.braindev.2016.09.011","article-title":"Severe leukoencephalopathy with cortical involvement and peripheral neuropathy due to FOLR1 deficiency","volume":"39","author":"Kobayashi","year":"2017","journal-title":"Brain Dev"},{"key":"R10-3-20240831","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00415-016-8387-6","article-title":"Folinic acid therapy in cerebral folate deficiency: marked improvement in an adult patient","volume":"264","author":"Karin","year":"2017","journal-title":"J Neurol"},{"key":"R11-3-20240831","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1212\/WNL.0b013e3181c679df","article-title":"Congenital null mutations of the FOLR1 gene: a progressive neurologic disease and its treatment","volume":"73","author":"Cario","year":"2009","journal-title":"Neurology"},{"key":"R12-3-20240831","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ejpn.2016.05.021","article-title":"Neurological improvement following intravenous high-dose folinic acid for cerebral folate transporter deficiency caused by FOLR-1 mutation","volume":"20","author":"Delmelle","year":"2016","journal-title":"Eur J Paediatr Neurol"}],"container-title":["Journal of Pediatric Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jpn.JPN_76_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:23:03Z","timestamp":1787844183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jpn.JPN_76_20"}},"subtitle":["Cerebral Folate Transport Deficiency\u2013\u2013Two Children from Southern India"],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jpn.jpn_76_20","relation":{},"ISSN":["1817-1745"],"issn-type":[{"value":"1817-1745","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}